Efficacy and Safety of Ramelteon on Chronic Insomnia

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Chronic Insomnia
Interventions
DRUG

Ramelteon and Placebo (25 possible combinations total)

"Randomized sequence over two consecutive nights for a total of five treatment periods to include the following:~Ramelteon 4 mg, tablets, orally over two nights~Ramelteon 8 mg, tablets, orally over two nights~Ramelteon 16 mg, tablets, orally over two nights~Ramelteon 32 mg, tablets, orally over two nights~Ramelteon placebo-matching tablets, orally over two nights"

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT00915135 - Efficacy and Safety of Ramelteon on Chronic Insomnia | Biotech Hunter | Biotech Hunter